LIVE RNA Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

LIVE RNA General Information

Description

Developer of mRNA drugs. The company has an internationally advanced mRNA production platform and an in vivo drug delivery platform, providing patients with treatments that traditional medicine and existing drugs cannot achieve.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Room 101, Building 2, No. 30 Feipeng Road
  • Guangdong-Macao Cooperation Traditional Chinese Medicine Technology Industrial Park, Hengq
  • Zhuhai, Guangdong
  • China
Primary Industry
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • Room 101, Building 2, No. 30 Feipeng Road
  • Guangdong-Macao Cooperation Traditional Chinese Medicine Technology Industrial Park, Hengq
  • Zhuhai, Guangdong
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LIVE RNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jun-2021 Completed Generating Revenue
1. Seed Round 08-Jan-2020 Completed Startup
To view LIVE RNA’s complete valuation and funding history, request access »

LIVE RNA Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hengqin Financial Investment Government Minority
Livzon Pharmaceutical Group Corporation Minority
Tenyall Investment Venture Capital Minority
To view LIVE RNA’s complete investors history, request access »

LIVE RNA FAQs

  • When was LIVE RNA founded?

    LIVE RNA was founded in 2019.

  • Where is LIVE RNA headquartered?

    LIVE RNA is headquartered in Zhuhai, China.

  • What industry is LIVE RNA in?

    LIVE RNA’s primary industry is Drug Discovery.

  • Is LIVE RNA a private or public company?

    LIVE RNA is a Private company.

  • What is LIVE RNA’s current revenue?

    The current revenue for LIVE RNA is .

  • Who are LIVE RNA’s investors?

    Hengqin Financial Investment, Livzon Pharmaceutical Group, and Tenyall Investment have invested in LIVE RNA.

  • When was LIVE RNA acquired?

    LIVE RNA was acquired on 01-Jun-2021.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process